Featuring perspectives from Dr Natalie S Callander and Dr Paul G Richardson, including the following topics:

• Introduction: Clinical Trials We LOVE to Discuss (0:00)
• Mechanism of Action of Cereblon E3 Ligase Modulators (CELMoDs) (8:42)
• Available Efficacy Data with CELMoDs in the Management of Relapsed/Refractory Multiple Myeloma (MM) (15:59)
• Extramedullary Disease (19:23)
• Spectrum and Management of CELMoD-Associated Adverse Events (30:12)
• Ongoing Phase II and III Trials Evaluating CELMoDs for MM (34:53)

CME information and select publications